![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() 3B Pharmaceuticals 3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2008 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations San Francisco, US HQ Bozeman, US | Locations Berlin, DE HQ | Locations Arrasate, ES HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 2216% increase | Employees 5510% increase | Employees 26 | Employees 156% decrease |
Funding | ||||
Total funding raised | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 17m |

3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications.
View companyMicroliquid is a healthcare company that provides IVD and cell therapy solutions.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company